GRTXD · Galera Therapeutics, Inc. · Investor Relations
$18.99
At close · Aug 3
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about our ability to continue as a going concern through the 12 months from the date of the filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed May 14, 2026
Market Cap
$15.23M
Shares
802,149
Volume · Aug 3
2447
Avg daily vol (6 sessions)
1267
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2023-09-11 | Galera at H.C. Wainwright 25th Annual Global Investment Conference | Conference |
| 2023-08-10 | Galera Therapeutics Conference Call | Conference |
| 2022-11-29 | Galera at Piper Sandler Annual Healthcare Conference | Conference |
| 2022-09-12 | Galera at H.C. Wainwright 24th Annual Global Investment Conference | Conference |
| 2022-06-09 | Galera at Jefferies Healthcare Conference | Conference |
| 2022-01-10 | Galera at H.C. Wainwright BioConnect Conference | Conference |
| 2021-12-14 | Galera ROMAN Phase 3 Trial Update | Event |
| 2021-11-18 | Galera at Jefferies London Healthcare Conference | Conference |
| 2021-09-29 | Cantor Fitzgerald Global Healthcare Conference | Conference |
| 2021-09-23 | Galera Virtual KOL Event: Radiotherapy-Induced Severe Oral Mucositis in Patients with Head and Neck Cancer | Event |